<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.111040.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Case Report</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Case Report: Hyperemesis gravidarum, high transaminases level and prolonged prothrombin time: is it an acute liver injury?</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 1 approved with reservations]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Ennaifer</surname>
                        <given-names>Rym</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>El Mouldi</surname>
                        <given-names>Yosr</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-2758-087X</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Bouchabou</surname>
                        <given-names>Bochra</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Nakhli</surname>
                        <given-names>Abdelwahab</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-2511-4069</uri>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Hemdani</surname>
                        <given-names>Nesrine</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Triki</surname>
                        <given-names>Amel</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Department of Gastroenterology, Mongi Slim La Marsa Hospital, Tunis, 2046, Tunisia</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:yosrelmouldi@gmail.com">yosrelmouldi@gmail.com</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>9</day>
                <month>6</month>
                <year>2022</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2022</year>
            </pub-date>
            <volume>11</volume>
            <elocation-id>634</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>22</day>
                    <month>4</month>
                    <year>2022</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2022 Ennaifer R et al.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/11-634/pdf"/>
            <abstract>
                <p>
                    <bold>Background</bold>: Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting in the first trimester of pregnancy. It is considered a benign condition, but severe complications, fortunately rare, have been reported. Frequently, this condition is associated with a perturbed liver function tests, which remains without severe consequences. The clinical presentation may be suggestive of an acute liver injury (ALI), especially as the end of the first trimester approaches, pregnancy specific and non-specific liver diseases should be considered.</p>
                <p>
                    <bold>Case</bold>: A 28-year-old primigravida, 14-week pregnant woman affected by hyperemesis gravidarum, developed high transaminases level and spontaneously low prothrombin time (PT) ratio. An ALI was suspected as transaminases were very high and our patient was at the end of the first trimester. An exhaustive etiological work-up was negative. In the second line, the factor V assay was conducted, which showed a normal activity, and the vitamin K level was low. We therefore concluded that it was hyperhemesis gravidarum complicated by fluid and electrolyte disorders and vitamin K deficiency. She had parenteral rehydration and a proton pump inhibitor. She received intravenous vitamin K 10 mg daily for three days. The outcome was excellent without any maternal or fetal impact.</p>
                <p>
                    <bold>Conclusion</bold>: Hyperhemesis gravidarum is a common condition in the first trimester of pregnancy that usually has a favourable outcome. However, it is important to be attentive to possible complications, including vitamin K deficiency with its maternal and fetal consequences. On the other hand, in case of major disturbance of the liver function tests, we should not overlook acute liver injury and should not hesitate to initiate an adequate etilogical investigation.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>Hyperemesis</kwd>
                <kwd>Acute liver injury</kwd>
                <kwd>prothrombin time</kwd>
                <kwd>vitamin K</kwd>
            </kwd-group>
            <funding-group>
                <funding-statement>The author(s) declared that no grants were involved in supporting this work.</funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec id="sec7">
            <title>Editorial note</title>
            <p>Editorial note (14th June 2023): Following internal discussion and communication with the author, the F1000 Editorial Team have determined that oral informed consent to publish is acceptable in this instance; the anonymity of the patient is maintained and the oral informed consent to publish was documented in the patient&#x2019;s medical records. Peer review will now resume for this article.</p>
            <p>Editorial note (28th March 2023): Since publication, it has been brought to the attention of the Editorial Team that only oral informed consent was obtained from the patient for publication of this case report. As per our 
                <ext-link ext-link-type="uri" xlink:href="https://f1000research.com/about/policies#rihumans">research involving humans policy</ext-link>, case reports require written informed consent to be obtained as they contain potentially identifying information about individuals. We have requested that the authors obtain written informed consent to publish from the patient. Peer review activity has been suspended for this article until written informed consent is confirmed.</p>
        </sec>
        <sec id="sec1" sec-type="intro">
            <title>Introduction</title>
            <p>Nausea and vomiting are common in the first trimester of pregnancy and usually have an excellent outcome: most cases recover around week 20. However, some patients present a more severe form: hyperemesis gravidarum (HG). It is defined by incoercible vomiting leading to a weight loss of more than 5%, hydro-electrolytic disorders and ketosis. Frequently, this condition is associated with a perturbed liver function tests, mainly a mild elevation of transaminases and more rarely jaundice, which remains without severe consequences, particularly without hepatocellular failure.</p>
        </sec>
        <sec id="sec2">
            <title>Case report</title>
            <p>A 24 year-old primigravida patient, with no familial or personal medical history, was admitted at week 14 of pregnancy for severe vomiting refractory to the usual symptomatic treatment since one month with asthenia and recent bodyweight loss.</p>
            <p>On admission, she presented an altered general condition, signs of extracellular dehydration, and epigastric sensitivity in abdominal examination. Her axillary temperature was normal, the skin and mucous membranes were normal, the haemodynamic status was stable and there was no palpable goiter. The patient has no active bleeding and no abnormalities on neurological examination. Obstetrical examination was also normal. The urine test showed ketonuria without proteinuria.</p>
            <p>Abdominopelvic ultrasound ruled out anomalies of the biliary tract, hepatic veins thrombosis and obstetric emergencies.</p>
            <p>Laboratory analysis showed hypokalaemia at 2.4 mmol/l without other electrolyte disorder, elevated transaminases: serum aspartate aminotransferase (ASAT) 201 IU/l and serum alanine aminotransferase (ALAT) 648 IU/l (normal value &lt; 40) without cholestasis, total bilirubin 32 umol/l, spontaneously low prothrombin time (PT) ratio 40%, haemoglobin 10 g/dl. Thyroid function tests were normal. Bacterial urine sampling was negative in culture. Serum markers for viral hepatitis (A, B, C, E, EBV, CMV and HSV) were not detectable. Autoimmune antibodies were absent.</p>
            <p>Drug-induced hepatotoxicity was also ruled out, as the patient did not ingest any recent medicine or pharmacological therapy.</p>
            <p>Acute liver injury (ALI) was suspected. However, Factor V assay showed a normal activity, with low vitamin K levels. The diagnosis of HG complicated by fluid and electrolyte disorders and vitamin K deficiency was retained.</p>
            <p>As her PT continued to decrease, she received intravenous vitamin K 10 mg daily for 3 days. She had parenteral rehydration with correction of hypokalaemia. For vomiting, a proton pump inhibitor was prescribed.</p>
            <p>The outcome was excellent, with regression of vomiting, correction of water-electrolyte balance and a normal PT of 85%. On the other hand, liver function tests normalization was slower.</p>
        </sec>
        <sec id="sec3" sec-type="discussion">
            <title>Discussion</title>
            <p>HG is the most severe form of nausea and vomiting in the first trimester of pregnancy. Its prevalence is 0.3 to 1% of pregnancies.
                <sup>
                    <xref ref-type="bibr" rid="ref1">1</xref>
                </sup> Its pathophysiology remains unclear, but it is certainly multifactorial. This condition is considered a first trimester pregnancy-related liver disease as it is associated with liver function abnormalities in half of the cases.
                <sup>
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup> The transaminase elevation is usually moderate but can reach 1000 IU/L in rare cases. It predominates over ALAT.
                <sup>
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup> Alkaline phosphatase may double, and bilirubin increases up to 4 mg/dL. However, synthetic liver function remains intact, with normal coagulation profile and serum albumin levels, except in case of severe malnutrition.
                <sup>
                    <xref ref-type="bibr" rid="ref3">3</xref>
                </sup> Usually, these disorders disappear after the vomiting has stopped and the fluid and electrolyte disorders have been resolved.
                <sup>
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup>
            </p>
            <p>The aetiology of liver damage during HG is not well known, but several factors may be involved: dehydration, malnutrition, human chorionic gonadotropin (HCG) and placental-derived cytokines such as tumor necrosis factor-alpha.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup>
            </p>
            <p>Normal pregnancy has no effect on ASAT and ALAT. Therefore, in case of liver enzymes anomalies, other causes, both non-specific and specific to pregnancy, should be ruled out, in particular those that can lead to hepatocellular failure and that require urgent treatment.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup> It has to be emphasized that most pregnancy-related liver diseases occur in the second and third trimesters. The diagnosis of liver disease secondary to HG remains a diagnosis of exclusion. Our patient was at the end of the first trimester (week 14), we were therefore alarmed at the fall of PT ratio, fearing other pregnancy specific liver diseases.</p>
            <p>Severe complications, fortunately rare, have also been reported in HG.
                <sup>
                    <xref ref-type="bibr" rid="ref5">5</xref>
                </sup> Mallory-Weiss syndrome, oesophageal rupture, inhalation pneumonitis, splenic avulsion, retinal haemorrhage and vitamin deficiency due to malabsorption secondary to incoercible vomiting: Gayet-Wernicke encephalopathy and a coagulopathy secondary to vitamin K deficiency. The latter was first described in 1998
                <sup>
                    <xref ref-type="bibr" rid="ref5">5</xref>
                </sup> in a patient admitted for management of HG, who presented with profuse epistaxis and whose various investigations of blood haemostasis and liver function concluded that she was vitamin K deficient.</p>
            <p>In our patient&#x2019;s case, an ALI was suspected based on the significant elevation of transaminases and the low PT. We therefore performed the standard work-up. We also tested for factor V activity to be sure that liver synthetic functions were correct. Then we confirmed the diagnosis of vitamin K deficiency by determining vitamin K blood level.</p>
            <p>Vitamin K is a fat-soluble vitamin, absorbed in the small intestine, mainly the jejunum, in the presence of bile salts. Reserves are low and are mainly in the liver. It has a key role in coagulation. Recommended intakes are usually largely covered by the diet. The aetiologies of vitamin K deficiency are diverse: lack of intake, intestinal malabsorption, liver dysfunction or the use of anti-vitamin K drugs (warfarin). In HG, vitamin K deficiency due to inadequate intake secondary to incoercible vomiting may be present in 26% of patients.
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup>
            </p>
            <p>It can have serious consequences for both the mother and the foetus: vitamin K deficiency embryopathy, maternal haemorrhage and neonatal cranial haemorrhage.
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup> Vitamin K deficiency embryopathy includes Binder phenotype and chondrodysplasia punctata.</p>
            <p>Screening for haemostasis disorders by performing a PT could allow early diagnosis and correction of the deficiency by vitamin K supplementation before the onset of these consequences.</p>
            <p>HG management usually includes fluid and electrolyte correction, intravenous antiemetic therapy and vitamin supplementation. Indeed, vitamin B1 supplementation to prevent Wernicke&#x2019;s encephalopathy is recommended and commonly practiced. Several studies suggest prophylactic vitamin K supplementation for hyperemesis gravidarum with severe malnutrition or weight loss. It remains to be proven whether early prophylactic vitamin K supplementation is safe and effective in preventing complications, especially embryopathy.
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup>
            </p>
            <p>For our patient, no foetal anomalies were detected on perinatal ultrasound. PT was not performed in the context of a bleeding complication or embryopathy, but rather systematically. She did not receive initially prophylactic supplementation.</p>
        </sec>
        <sec id="sec4" sec-type="conclusion">
            <title>Conclusion</title>
            <p>HG is generally considered as a benign condition. However, it should be kept in mind that HG could lead to coagulopathy by means of vitamin K deficiency, in order to avoid maternal and foetal complications. In this context, the disturbance of liver function tests associated with a low PT must lead to the suspicion of ALI and therefore initiate an appropriate etiological investigation. Collaboration between the hepatologist and gynaecologist is essential for better management.</p>
        </sec>
        <sec id="sec5">
            <title>Data availability</title>
            <p>All data underlying the results are available as part of the article and no additional source data are required.</p>
        </sec>
        <sec id="sec6">
            <title>Consent</title>
            <p>Oral informed consent for publication of their clinical details and/or clinical images was obtained from the patient during her hospital stay and noted in her medical record.</p>
        </sec>
    </body>
    <back>
        <ref-list>
            <title>References</title>
            <ref id="ref1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bacq</surname>
                            <given-names>Y</given-names>
                        </name>
</person-group>:
                    <article-title>H&#x00e9;patopathies gravidiques.</article-title>
                    <source>

                        <italic toggle="yes">H&#x00e9;pato-Gastro &amp; Oncologie Digestive.</italic>
</source>
                    <year>2013</year>;<volume>20</volume>(<issue>8</issue>):<fpage>583</fpage>&#x2013;<lpage>592</lpage>.
                    <pub-id pub-id-type="doi">10.1684/hpg.2013.0922</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Gaba</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gaba</surname>
                            <given-names>S</given-names>
                        </name>
</person-group>:
                    <article-title>Study of Liver Dysfunction in Hyperemesis Gravidarum.</article-title>
                    <source>

                        <italic toggle="yes">Cureus.</italic>
</source>
                    <year>2020 Jun 20</year>;<volume>12</volume>(<issue>6</issue>):<fpage>e8709</fpage>.
                    <pub-id pub-id-type="pmid">32699704</pub-id>
                    <pub-id pub-id-type="doi">10.7759/cureus.8709</pub-id>
                    <pub-id pub-id-type="pmcid">PMC7372213</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Varlas</surname>
                            <given-names>VN</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Boh&#x00ee;ltea</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gheorghe</surname>
                            <given-names>G</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>State of the Art in Hepatic Dysfunction in Pregnancy.</article-title>
                    <source>

                        <italic toggle="yes">Healthcare.</italic>
</source>
                    <year>2021</year>;<volume>9</volume>:<fpage>1481</fpage>.
                    <pub-id pub-id-type="pmid">34828527</pub-id>
                    <pub-id pub-id-type="doi">10.3390/healthcare9111481</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sasamori</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Tanaka</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ayabe</surname>
                            <given-names>T</given-names>
                        </name>
</person-group>:
                    <article-title>Liver disease in pregnancy.</article-title>
                    <source>

                        <italic toggle="yes">Hepatol. Res.</italic>
</source>
                    <year>2020 Sep</year>;<volume>50</volume>(<issue>9</issue>):<fpage>1015</fpage>&#x2013;<lpage>1023</lpage>.
                    <pub-id pub-id-type="pmid">32583511</pub-id>
                    <pub-id pub-id-type="doi">10.1111/hepr.13540</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Robinson</surname>
                            <given-names>JN</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Banerjee</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Thiet</surname>
                            <given-names>MP</given-names>
                        </name>
</person-group>:
                    <article-title>Coagulopathy secondary to vitamin K deficiency in hyperemesis gravidarum.</article-title>
                    <source>

                        <italic toggle="yes">Obstet. Gynecol.</italic>
</source>
                    <year>1998 Oct</year>;<volume>92</volume>(<issue>4 Pt 2</issue>):<fpage>673</fpage>&#x2013;<lpage>675</lpage>.
                    <pub-id pub-id-type="pmid">9764659</pub-id>
                    <pub-id pub-id-type="doi">10.1016/s0029-7844(98)00150-1</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Nijsten</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Minnen</surname>
                            <given-names>L</given-names>
                            <prefix>van der</prefix>
                        </name>

                        <name name-style="western">
                            <surname>Wiegers</surname>
                            <given-names>HMG</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Hyperemesis gravidarum and vitamin K deficiency: a systematic review.</article-title>
                    <source>

                        <italic toggle="yes">Br. J. Nutr.</italic>
</source>
                    <year>2021 Jul</year>;<volume>30</volume>:<fpage>1</fpage>&#x2013;<lpage>13</lpage>.
                    <pub-id pub-id-type="pmid">34325760</pub-id>
                    <pub-id pub-id-type="doi">10.1017/S0007114521002865</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report236742">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.122712.r236742</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Trovik</surname>
                        <given-names>Jone</given-names>
                    </name>
                    <xref ref-type="aff" rid="r236742a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-3808-6407</uri>
                </contrib>
                <aff id="r236742a1">
                    <label>1</label>University of Bergen, Bergen, Norway</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>23</day>
                <month>1</month>
                <year>2024</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Trovik J</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport236742" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.111040.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The authors&#x00a0;describe&#x00a0;a woman&#x00a0;with&#x00a0;severe nausea&#x00a0;and vomiting&#x00a0;in pregnancy; hyperemesis gravidarum,&#x00a0;hospitalized&#x00a0;with&#x00a0;weight&#x00a0;loss (not stated&#x00a0;amount&#x00a0;of&#x00a0;weight&#x00a0;loss) prescribed&#x00a0;"usual&#x00a0;symptomatic&#x00a0;treatment" (not specified) and at admission&#x00a0;detected&#x00a0;elevated&#x00a0;liver enzymes. Acute&#x00a0;liver injury&#x00a0;was&#x00a0;suspected&#x00a0;and during evaluation&#x00a0;(no&#x00a0;time frame&#x00a0;noted) she&#x00a0;was&#x00a0;diagnosed&#x00a0;with&#x00a0;vitamin-K deficiency&#x00a0;and prescribed&#x00a0;vitamin-K intravenously.&#x00a0;</p>
            <p> The description&#x00a0;of&#x00a0;treatment&#x00a0;provided&#x00a0;is insufficient.&#x00a0;What&#x00a0;was&#x00a0;provided&#x00a0;as antiemetics? Did&#x00a0;this&#x00a0;relieve&#x00a0;her nausea&#x00a0;and&#x00a0;vomiting? But&#x00a0;most important&#x00a0;for this&#x00a0;patient&#x00a0;history:&#x00a0;did&#x00a0;she&#x00a0;receive&#x00a0;any nutritional&#x00a0;therapy apart from vitamins (parenteral or enteral, not only&#x00a0;fluids to correct dehydration/electrolyte imbalance). And with&#x00a0;regard&#x00a0;to any&#x00a0;nutritional&#x00a0;treatment; was&#x00a0;her food&#x00a0;intake&#x00a0;monitored? What&#x00a0;about&#x00a0;noting&#x00a0;her&#x00a0;weight&#x00a0;loss initially&#x00a0;(from prepregnant weight&#x00a0;until&#x00a0;admission) and was&#x00a0;any&#x00a0;weight&#x00a0;gain&#x00a0;during hospital stay&#x00a0;noted&#x00a0;or further&#x00a0;weight&#x00a0;gain&#x00a0;until&#x00a0;end of&#x00a0;pregnancy/until&#x00a0;delivery?&#x00a0;</p>
            <p> What was&#x00a0;the&#x00a0;length of&#x00a0;pregnancy&#x00a0;(gestational&#x00a0;length)&#x00a0;when&#x00a0;she&#x00a0;delivered?&#x00a0;What&#x00a0;was&#x00a0;the&#x00a0;baby's&#x00a0;weight&#x00a0;at birth?&#x00a0;What&#x00a0;was&#x00a0;the&#x00a0;maternal weight&#x00a0;at delivery/end of&#x00a0;pregnancy?&#x00a0;&#x00a0;</p>
            <p> As an obstetrician&#x00a0;these&#x00a0;information's&#x00a0;are&#x00a0;very&#x00a0;important&#x00a0;in assessing&#x00a0;health&#x00a0;during pregnancy!&#x00a0;</p>
            <p> The discussion&#x00a0;regarding&#x00a0;etiology&#x00a0;is sufficient.&#x00a0;</p>
            <p> This case point&#x00a0;to an important&#x00a0;aspect&#x00a0;of&#x00a0;hyperemesis; insufficient&#x00a0;nutritional&#x00a0;intake, and also&#x00a0;point&#x00a0;to the&#x00a0;general lack&#x00a0;of&#x00a0;health&#x00a0;carers&#x00a0;assessing&#x00a0;and providing adequate&#x00a0;nutritional&#x00a0;treatment&#x00a0;for a woman&#x00a0;with&#x00a0;nausea&#x00a0;and vomiting&#x00a0;24/7! I would&#x00a0;very&#x00a0;much&#x00a0;like the&#x00a0;authors&#x00a0;to provide&#x00a0;additional&#x00a0;information&#x00a0;regarding&#x00a0;these&#x00a0;aspects.</p>
            <p>Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?</p>
            <p>Partly</p>
            <p>Is the case presented with sufficient detail to be useful for other practitioners?</p>
            <p>Yes</p>
            <p>Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?</p>
            <p>Partly</p>
            <p>Is the background of the case&#x2019;s history and progression described in sufficient detail?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>gynecology, hyperemesis gravidarum, nutritional treatment in early pregnancy</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment16332-236742">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>EL MOULDI</surname>
                            <given-names>Yosr</given-names>
                        </name>
                        <aff>Hopital Mongi Slim La Marsa, Tunisia</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>1</day>
                    <month>6</month>
                    <year>2026</year>
                </pub-date>
            </front-stub>
            <body>
                <p>Dear Reviewer,</p>
                <p> </p>
                <p> We sincerely thank you for your careful and constructive review of our manuscript. Your comments are highly relevant and allow us to substantially improve the quality and clinical utility of this case report. Please find below our detailed responses to each point raised.</p>
                <p> </p>
                <p> 1. Antiemetic treatment and symptomatic response</p>
                <p> We acknowledge that the description of symptomatic treatment was insufficiently detailed in the original manuscript. The patient received intravenous metoclopramide and intravenous omeprazole. A partial and progressive improvement in nausea and vomiting was observed over the course of hospitalization. It is also noteworthy that, as the patient was at 14 weeks of gestation at admission, the natural resolution of hyperemesis gravidarum symptoms &#x2014; which typically subside during the second trimester &#x2014; likely contributed to her clinical improvement. These details have been added to the Case Report section of the revised manuscript.</p>
                <p> </p>
                <p> **2. Nutritional management</p>
                <p> The patient did not receive parenteral nutrition. She was managed with oral enteral nutrition, adapted to her tolerance through meal fractionation &#x2014; small, frequent meals throughout the day. Intravenous fluid and electrolyte replacement was also administered. However, we acknowledge that no formal monitoring of caloric intake was performed during hospitalization, which represents a limitation of the management provided and is, in fact, one of the key educational messages of this case report.</p>
                <p> We have revised the Discussion section to explicitly emphasize that adequate nutritional assessment and support should be considered an integral part of the management of hyperemesis gravidarum, particularly when complicated by biochemical abnormalities suggestive of malnutrition.</p>
                <p> </p>
                <p> </p>
                <p> **3. Weight data</p>
                <p> Unfortunately, pre-pregnancy weight and weight at admission were not documented in the patient's medical records, precluding the calculation of gestational weight loss. No systematic weight monitoring was performed during hospitalization. We recognize this as a significant limitation, both in terms of patient management and case reporting. This has been explicitly stated as a limitation in the revised manuscript.&#x00a0;</p>
                <p> </p>
                <p> </p>
                <p> **4. Obstetric outcomes&#x00a0;</p>
                <p> Regrettably, obstetric outcome data are unavailable. Following her discharge, the patient continued her antenatal follow-up at a different hospital, and we were unable to retrieve information regarding gestational age at delivery, birth weight, maternal weight at delivery, or the occurrence of any perinatal complications. This represents an important limitation of the present case report and has been clearly acknowledged as such in the revised manuscript.</p>
                <p> We agree with the reviewer that these data would have significantly strengthened the assessment of maternal and fetal wellbeing in the context of prolonged nutritional deficiency.&#x00a0;</p>
                <p> </p>
                <p> </p>
                <p> We believe that the revised manuscript better reflects the clinical reality encountered in practice and delivers a clearer and more actionable message for healthcare providers managing patients with hyperemesis gravidarum. We hope that these revisions adequately address your concerns and that the manuscript may now be considered suitable for indexing.</p>
                <p> </p>
                <p> We remain at your disposal for any further clarification.</p>
                <p> </p>
                <p> Yours sincerely,</p>
                <p> </p>
                <p> Dr. Y. El Mouldi</p>
                <p> Department of Gastroenterology, H&#x00f4;pital Mongi Slim</p>
                <p> On behalf of all co-authors</p>
            </body>
        </sub-article>
    </sub-article>
</article>
